• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Pericardial Effusion

Pericardial Effusion - 15 Studies Found

Completed : Non Steroidal Anti Inflammatory Treatment for Post Operative Pericardial Effusion
: Pericardial Effusion
: 2005-10-28
:
  • Drug: diclofenac diclofenac 50

Completed : Cochicine Treatment for Post- Operative Pericardial Effusion
: Pericardial Effusion
: 2010-12-23
:
  • Drug: Colchicines oral form, 1

Completed : Impact of Colchicine Therapy on Arrhythmia Recurrence After Acute Pericardial Effusion
: Pericardial Effusion
: 2014-10-05
: Drug: Colchicine Impact of Colchicine therapy on arrhythmia Recurrence after Acute Pericardial Effusion
Completed : IMPI 2 - A Trial of Intrapericardial Alteplase in Large Pericardial Effusion
: Pericardial Effusion
: 2016-02-01
:
  • Other: Pericardiocentesis with Alteplase

Completed : Trial of Drainage With or Without Bleomycin Instillation for Malignant Pericardial Effusion
: Malignant Pericardial Effusion
: 2005-08-19
:
  • Procedure: Observation alone after pericardial drainage

Completed : Pleural and Pericardial Effusion Following Open Heart Surgery
:
  • Heart Disease
  • Pleural Effusion
  • Peric
    : 2014-01-21
    : Procedure: pleuracentesis Direct needle drainage of pleural effusions with dynamic ultrasound technique
Enrolling by invitation : Intrapleural Bevacizumab Injection for Malignant Effusion in Lung Cancer
:
  • Non-small Cell Lung Cancer
  • Malignant Pleural Effusion

: 2014-01-27
: Drug: Bevacizumab Bevacizumab 100 mg, intrapleural injection treating MPE after the drainage of MPE
Enrolling by invitation : COlchicine for Prevention of the Post-pericardiotomy Syndrome and Post-operative Atrial Fibrillation (COPPS-2 Trial)
:
  • Cardiac Surgery
  • Post-pericardiotomy Syndrome
  • Atrial Fibril
    : 2012-03-06
    :
    • Drug: Colchicine Colchicine 0.

Completed : Phase I/II Safety Study of IPI-504 in Relapsed/Refractory Stage IIIb, or Stage IV Non-small Cell Lung Cancer (NSCLC)
: Lung Cancer
: 2007-01-31
: Drug: IPI-504 IV Hsp90 inhibitor
Completed : Triplet Combination First Line Treatment in Non Small Cell Lung Cancer (NSCLC)
: Metastatic Non-squamous Non Small Cell Lung Cancer
: 2009-07-17
:
  • Drug: CBP501 + Cisplatin + Pemetrexed

Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.